351 related articles for article (PubMed ID: 34025663)
1. Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by
Erturk-Hasdemir D; Ochoa-Repáraz J; Kasper DL; Kasper LH
Front Immunol; 2021; 12():662807. PubMed ID: 34025663
[TBL] [Abstract][Full Text] [Related]
2. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor.
Erturk-Hasdemir D; Kasper DL
Ann N Y Acad Sci; 2018 Apr; 1417(1):116-129. PubMed ID: 29528123
[TBL] [Abstract][Full Text] [Related]
3. The Intestinal Commensal, Bacteroides fragilis, Modulates Host Responses to Viral Infection and Therapy: Lessons for Exploration during Mycobacterium tuberculosis Infection.
Eribo OA; du Plessis N; Chegou NN
Infect Immun; 2022 Jan; 90(1):e0032121. PubMed ID: 34606367
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.
Ochoa-Repáraz J; Mielcarz DW; Ditrio LE; Burroughs AR; Begum-Haque S; Dasgupta S; Kasper DL; Kasper LH
J Immunol; 2010 Oct; 185(7):4101-8. PubMed ID: 20817872
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide A of Bacteroides fragilis: actions on dendritic cells and T cells.
Kayama H; Takeda K
Mol Cell; 2014 Apr; 54(2):206-7. PubMed ID: 24766882
[TBL] [Abstract][Full Text] [Related]
6. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.
Ochoa-Repáraz J; Mielcarz DW; Wang Y; Begum-Haque S; Dasgupta S; Kasper DL; Kasper LH
Mucosal Immunol; 2010 Sep; 3(5):487-95. PubMed ID: 20531465
[TBL] [Abstract][Full Text] [Related]
7. A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation.
Wang Y; Begum-Haque S; Telesford KM; Ochoa-Repáraz J; Christy M; Kasper EJ; Kasper DL; Robson SC; Kasper LH
Gut Microbes; 2014 Jul; 5(4):552-61. PubMed ID: 25006655
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.
Dasgupta S; Erturk-Hasdemir D; Ochoa-Reparaz J; Reinecker HC; Kasper DL
Cell Host Microbe; 2014 Apr; 15(4):413-23. PubMed ID: 24721570
[TBL] [Abstract][Full Text] [Related]
9. Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis.
Ramakrishna C; Kujawski M; Chu H; Li L; Mazmanian SK; Cantin EM
Nat Commun; 2019 May; 10(1):2153. PubMed ID: 31089128
[TBL] [Abstract][Full Text] [Related]
10. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
Telesford KM; Yan W; Ochoa-Reparaz J; Pant A; Kircher C; Christy MA; Begum-Haque S; Kasper DL; Kasper LH
Gut Microbes; 2015 Jul; 6(4):234-42. PubMed ID: 26230152
[TBL] [Abstract][Full Text] [Related]
11. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
Ochoa-Repáraz J; Kasper LH
Transl Res; 2017 Jan; 179():126-138. PubMed ID: 27519147
[TBL] [Abstract][Full Text] [Related]
12. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
14. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.
Surana NK; Kasper DL
Immunol Rev; 2012 Jan; 245(1):13-26. PubMed ID: 22168411
[TBL] [Abstract][Full Text] [Related]
15. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
17. A tale of two habitats:
Patrick S
Microbiology (Reading); 2022 Apr; 168(4):. PubMed ID: 35404220
[No Abstract] [Full Text] [Related]
18. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system.
Troy EB; Kasper DL
Front Biosci (Landmark Ed); 2010 Jan; 15(1):25-34. PubMed ID: 20036803
[TBL] [Abstract][Full Text] [Related]
20. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.
Mazmanian SK; Liu CH; Tzianabos AO; Kasper DL
Cell; 2005 Jul; 122(1):107-18. PubMed ID: 16009137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
